跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MINT-METRONIDAZOLE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MINT-METRONIDAZOLE
Authorized
STANDARD
MINT-METRONIDAZOLE
mint pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6ab9c42c4a8b0e09
Company
mint pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
6ab9c42c4a8b0e09
Drug Approval Canada Name
MINT-METRONIDAZOLE
Product Name
MINT-METRONIDAZOLE
Status
Marketed
Status Date
2023-09-07
Original Market Date
2023-09-07
Din
02535807
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:30.92
Atc Original
P01AB01 METRONIDAZOLE
Atc Name
p 01 ab 01
Aig Number
0102572001
Company Name
mint pharmaceuticals inc
Company Address
6575 Davand Drive, Mississauga, Ontario, Canada, L5T 2M3
Active Ingredients
METRONIDAZOLE
250 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6ab9c42c4a8b0e09
Type
Standard
Back to Health Canada Approvals